Skip to Main Content

Paper Details

Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns.
Clin Cancer Res
0
2022
1p/19q-codeleted, CCNU, CNS, CNS WHO Grade 2 and 3 Oligodendroglioma, DNA, IDH, Illumina MethylationEPIC 850k microarrays, MGMT, O6-methylguanine, O6-methylguanine methyltransferase, PCV, Temozolomide, genome, grade 3, isocitrate, isocitrate dehydrogenase, lomustine, oligodendroglioma, patients, procarbazine, tumor, tumor tissue, vincristine
Author NameAffiliation
Adelheid WoehrerMedical University of Vienna
Georg WidhalmMedical University of Vienna
Karin DieckmannMedical University of Vienna
Serge WeisKepler University Hospital, Johannes Kepler University Linz
Julia FurtnerMedical University of Vienna
Josef PichlerKepler University Hospital, Johannes Kepler University Linz
Matthias PreusserMedical University of Vienna
Matthias PreusserMedical University of Vienna
Anna S BerghoffMedical University of Vienna
  • 1 - 9

Datasets

Release 1.2